Cardionovum

Be up
to date.

Latest press release

RESTORE® Drug-Coated Balloon receives first Chinese FDA medical device registration certificate for two indications

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Learn more >>

J.C. van den Berg discusses results from the APERTO AVF study

Learn more >>

Koen Deloose discusses final results from the Reflow trial

Learn more >>

Matteo Tozzi discusses new data from the APERTO AVF study

Learn more >>

Dr. Bosier interview at LINC 2019

Learn more >>

CARDIONOVUM Press Release: RESTORE® Drug-Coated Balloon Matches Zotarolimus-Eluting Stent in Patients with Coronary Small Vessel Lesions

Learn more >>

Upcoming events

Currently there are no events.

Latest events

Cardionovum at LINC

Cardionovum participates at LINC Leipzig Interventional Course

Date: Jan 30, 2018–Feb 03, 2018

Location: Leipzig, Germany

Learn more >>

Visit website >>

Cardionovum at CIRSE annual meeting

Cardionovum participates at CIRSE meeting.

Date: Sep 16, 2017–Sep 21, 2017

Location: Copenhagen, Denmark

Visit website >>

Cardionovum at SCR’17

Cardionovum participates at the Swiss Congress of Radiology SCR’17 Bern.

Date: June 08, 2017–June 11, 2017

Location: Kursaal Bern, Switzerland

Learn more >>

Visit website >>

go top